• Return to Headlines

Lion Biotechnolo Has Returned 8.6% Since SmarTrend Recommendation (LBIO)

By Amy Schwartz

SmarTrend identified an Uptrend for Lion Biotechnolo (:LBIO) on June 19th, 2017 at $6.40. In approximately 22 months, Lion Biotechnolo has returned 8.59% as of today's recent price of $6.95.

Over the past year, Lion Biotechnolo has traded in a range of $6.80 to $7.50 and is now at $6.95, 2% above that low. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has remained constant.

Lion Biotechnologies Inc. is engaged in the development and commercialization of a novel autologous cell therapy (ACT) for the treatment of various cancers. The Company also expects to initiate a clinical trial with its lead product candidate, which is an autologous cell therapy using TILs as a second line treatment for Stage IV metastatic melanoma.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Lion Biotechnolo shares.

Log in and add Lion Biotechnolo (LBIO) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights :lbio lion biotechnolo

Ticker(s): LBIO